Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
21.4M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
487K
-
Shares change
-
-431K
-
Total reported value, excl. options
-
$817K
-
Value change
-
-$780K
-
Number of buys
-
3
-
Number of sells
-
-11
-
Price
-
$1.68
Significant Holders of Imunon, Inc. - Common stock, par value $0.01 per share (IMNN) as of Q3 2022
17 filings reported holding IMNN - Imunon, Inc. - Common stock, par value $0.01 per share as of Q3 2022.
Imunon, Inc. - Common stock, par value $0.01 per share (IMNN) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 487K shares
of 21.4M outstanding shares and own 2.28% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (152K shares), TWO SIGMA ADVISERS, LP (92K shares), BlackRock Inc. (67.4K shares), RENAISSANCE TECHNOLOGIES LLC (53.5K shares), GEODE CAPITAL MANAGEMENT, LLC (49.5K shares), CITADEL ADVISORS LLC (31.9K shares), STATE STREET CORP (14.3K shares), Virtu Financial LLC (10.9K shares), Tower Research Capital LLC (TRC) (8.01K shares), and INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV (5K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.